[Congressional Record Volume 168, Number 133 (Saturday, August 6, 2022)]
[Senate]
[Page S4335]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5391. Mr. MARSHALL submitted an amendment intended to be proposed 
to amendment SA 5194 proposed by Mr. Schumer to the bill H.R. 5376, to 
provide for reconciliation pursuant to title II of S. Con. Res. 14; 
which was ordered to lie on the table; as follows:

        At the end of part 1 of subtitle B of title I, add the 
     following:

     SEC. 11005. CONSULTATION REQUIREMENT.

       As a condition of implementing the provisions of, including 
     the amendments made by, section 11001 and 11002, the 
     Government Accountability Office shall to submit a report to 
     Congress with recommendations to ensure that the 
     implementation of such provisions does not--
       (1) negatively impact the United States pharmaceutical 
     industry market competitiveness with China regarding 
     biopharmaceutical innovation and domestic manufacturing 
     capacity; or
       (2) increase the United States' current importation levels 
     of essential generic drugs and drugs on the FDA shortages 
     list that are produced or manufactured by foreign entities in 
     China.
                                 ______